ES2062752T3 - Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia. - Google Patents

Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.

Info

Publication number
ES2062752T3
ES2062752T3 ES91900357T ES91900357T ES2062752T3 ES 2062752 T3 ES2062752 T3 ES 2062752T3 ES 91900357 T ES91900357 T ES 91900357T ES 91900357 T ES91900357 T ES 91900357T ES 2062752 T3 ES2062752 T3 ES 2062752T3
Authority
ES
Spain
Prior art keywords
salt
oxypurinol
hyperuricemia
prepared
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900357T
Other languages
English (en)
Inventor
Veit Nitsche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOKINET CHEM LAB
Original Assignee
BIOKINET CHEM LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOKINET CHEM LAB filed Critical BIOKINET CHEM LAB
Application granted granted Critical
Publication of ES2062752T3 publication Critical patent/ES2062752T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA COMPOSICION TERAPEUTICA QUE PUEDE ADMINISTRARSE ORALMENTE Y ES UTIL PARA TRATAR LA HIPERURECEMIA, CONTIENE COMO INGREDIENTE ACTIVO UNA SAL DE OXIPURINOL. SE DESCRIBE TAMBIEN EL USO DE LA COMPOSICION.
ES91900357T 1989-12-28 1990-12-20 Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia. Expired - Lifetime ES2062752T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0295889A AT396427B (de) 1989-12-28 1989-12-28 Pharmazeutische verwendung eines oxipurinolsalzes

Publications (1)

Publication Number Publication Date
ES2062752T3 true ES2062752T3 (es) 1994-12-16

Family

ID=3543074

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900357T Expired - Lifetime ES2062752T3 (es) 1989-12-28 1990-12-20 Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.

Country Status (8)

Country Link
EP (1) EP0461218B1 (es)
AT (1) AT396427B (es)
AU (1) AU647444B2 (es)
DE (1) DE59003806D1 (es)
DK (1) DK0461218T3 (es)
ES (1) ES2062752T3 (es)
RU (1) RU2016571C1 (es)
WO (1) WO1991009600A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083687A1 (en) * 2005-01-28 2006-08-10 Cardiome Pharma Corp. Crystal salt of xanthine oxidase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans
ZA871813B (en) * 1986-03-13 1988-10-26 Wellcome Found Cell protection

Also Published As

Publication number Publication date
AU6968791A (en) 1991-07-24
DE59003806D1 (de) 1994-01-20
AT396427B (de) 1993-09-27
WO1991009600A1 (de) 1991-07-11
ATA295889A (de) 1993-01-15
AU647444B2 (en) 1994-03-24
RU2016571C1 (ru) 1994-07-30
EP0461218B1 (de) 1993-12-08
EP0461218A1 (de) 1991-12-18
DK0461218T3 (da) 1994-04-18

Similar Documents

Publication Publication Date Title
BRPI0108977B8 (pt) compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
DE69724647D1 (de) Acyclovirhaltige antiherpesarzneistift zur topischen anwendung
ES491621A0 (es) Procedimiento para producir un preparado farmaceutico en forma de una pelicula de poliacrilato, adecuado para aplicacionpor via transdermal.
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
DE60143911D1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
AR040248A1 (es) Farmaco para el tratamiento de la vejiga hiperactiva
ATE15596T1 (de) Pharmazeutische mittel.
BR9916860A (pt) Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
AR026197A1 (es) Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina
ES2139673T3 (es) Utilizacion de norastemizol para el tratamiento de rinitis alergica.
ES2157107T3 (es) Uso de moxonidina para el tratamiento del dolor neuropatico.
BR9815098A (pt) Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
AR026254A1 (es) El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
DE10299023I1 (de) Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.
UY26459A1 (es) 3,4-dihidroquinazolinas 5,6-disustituidas
ATE247462T1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
ATE298240T1 (de) Getrennte dosis therapien mit gefässschädigender aktivität
JP2002501021A5 (es)
AR020815A1 (es) Procedimiento para el tratamiento de la esquizofrenia, como tambien medios para ser utilizados en dicho procedimiento
CO5031290A1 (es) Formulacion lo
BR0317292A (pt) Derivados de amida de ácido antranìlico e seu uso farmacêutico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 461218

Country of ref document: ES